US Stock MarketDetailed Quotes

PTIX Protagenic Therapeutics

Watchlist
  • 0.6082
  • -0.0469-7.16%
Close Nov 1 16:00 ET
  • 0.5400
  • -0.0682-11.21%
Post 18:09 ET
2.72MMarket Cap-419P/E (TTM)

About Protagenic Therapeutics Company

Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.

Company Profile

SymbolPTIX
Company NameProtagenic Therapeutics
Listing DateApr 27, 2021
Issue Price4.50
Founded1994
CEODr. Garo H. Armen, Pd.D
MarketNASDAQ
Employees3
Fiscal Year Ends12-31
Address149 Fifth Avenue,Suite 500
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10010
Phone1-212-994-8200
Websitehttp://www.protagenic.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Robert B. Stein, M.D.,PhD
  • Director and Chief Medical Officer
  • --
  • Andrew Slee
  • Chief Operating Officer
  • --
  • Dr. Alexander K. Arrow, M.D.
  • Chief Financial Officer
  • 150.00K
  • Dr. Garo H. Armen, Pd.D
  • Executive Chairman of the Board and Principal Executive Officer
  • --
  • Dr. Jennifer S. Buell, PhD
  • Director
  • --
  • Khalil Barrage
  • Independent Director
  • --
  • Timothy R. Wright
  • Lead Independent Director
  • --
  • Brian J. Corvese
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data